Reuters logo
BRIEF-Cardinal Health to sell its china business to Shanghai Pharma for $1.2 bln‍​
November 15, 2017 / 1:50 AM / 3 days ago

BRIEF-Cardinal Health to sell its china business to Shanghai Pharma for $1.2 bln‍​

Nov 14 (Reuters) - Cardinal Health Inc -

* Cardinal health signs definitive agreement to sell its china business to Shanghai Pharma

* Deal for $1.2 bln‍​

* ‍Does not include Cardinal’s remaining businesses in China, including Cordis, its medical sourcing team

* ‍Sale includes Cardinal Health’s pharmaceutical and medical products distribution business in China​

* ‍Eric Zwisler, chairman of Cardinal Health China, will retire effective immediately as part of sale​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below